# Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

> **NCT00533481** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 497 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** MK0557

## Key facts

- **NCT ID:** NCT00533481
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 497 (ACTUAL)
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533481, "Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00533481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*